2025 Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Patryk Sobieralski Journal Bone Marrow Transplant.
2025 Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee Group Practice Harmonisation and Guidelines Committee 1st listed author Jaime Sanz Journal Lancet Oncol.
2025 Operational burden and fragmented implementation in CAR T-cell therapy: Insights from a multinational survey by the GoCART Coalition and the JACIE Quality Managers Committee Group Quality Managers Committee GoCART Coalition 1st listed author Nick van Sinderen Journal Hemasphere.
2025 Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging Group Inborn Errors Working Party (IEWP) Other society 1st listed author Emilie Pauline Buddingh Journal J Hum Immun.
2025 Late effects after hematopoietic stem cell transplantation in patients with HLH: A Histiocyte Society, PDWP, IEWP, and TCWP EBMT Study Group Inborn Errors Working Party (IEWP) Complications Working Party (CWP) Paediatric Diseases Working Party (PDWP) 1st listed author Kim Ramme Journal J Allergy Clin Immunol.
2025 Hematopoietic stem cell transplantation for purine nucleoside phosphorylase deficiency: an EBMT-IEWP retrospective study Group Inborn Errors Working Party (IEWP) 1st listed author Uli S Herrmann Journal Blood.
2025 Single unrelated umbilical cord blood versus unmanipulated haploidentical HCT using PTCy in pediatric AML: a retrospective study on behalf of the EBMT PDWP and CTIWP Group Cellular Therapy & Immunobiology Working Party (CTIWP) Paediatric Diseases Working Party (PDWP) 1st listed author Benedetta Elena Di Majo Journal Bone Marrow Transplant.
2025 Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party Group Paediatric Diseases Working Party (PDWP) 1st listed author Nimrod Buchbinder Journal Br J Haematol.
2025 BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party Group Autoimmune Diseases Working Party (ADWP) 1st listed author Raffaella Greco Journal Bone Marrow Transplant.
2025 Haploidentical versus matched unrelated donor hematopoietic cell transplantation for adult patients with refractory/relapsed acute lymphoblastic leukemia: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) Global Committee 1st listed author Yuhua Ru Journal Bone Marrow Transplant.
2025 Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party Group Complications Working Party (CWP) 1st listed author Agnieszka Piekarska Journal Bone Marrow Transplant.
2025 Similar Outcome With Haploidentical, Matched Sibling, or Matched Unrelated Donor Hematopoietic Cell Transplantation for Adult Patients With Adverse-Risk TP53-Mutated Acute Myeloid Leukemia in First Remission: A Comparative Study From the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) Global Committee 1st listed author Yuhua Ru Journal Am J Hematol.